Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Human iron deficiency].

Bernard Grosbois1, Olivier Decaux, Brengere Cador

  • 1Médecine Interne, Département de Médecine de l'adulte, CHU Hôpital Sud, 16, boulevard de Bulgarie. 35203 Rennes.

Bulletin De L'Academie Nationale De Medecine
|June 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initiating transformative medical practices to address environmental challenges - proceedings of "Santé en 2050", the French national conference on healthcare adaptation.

Reviews on environmental health·2026
Same author

A dexamethasone-free daratumumab-ixazomib regimen in frail elderly patients with relapsed or refractory multiple myeloma: Results of the IFM 2018-02 phase II study.

British journal of haematology·2026
Same author

Patient-Centered Education Through A Massive Open Online Course (MOOC) for Patients With Multiple Myeloma and Caregivers: Descriptive Study of Knowledge Gains by French Association of Patients With Multiple Myeloma (AF3M) and French-Speaking Myeloma Intergroup (IFM).

JMIR formative research·2026
Same author

Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study.

Blood advances·2026
Same author

Fetal and maternal outcome in the pregnancies of patients with systemic sclerosis and very early diagnosis of systemic sclerosis in France: a prospective study.

The Lancet. Rheumatology·2025
Same author

Safety and efficacy of a dexamethasone-sparing regimen with daratumumab and lenalidomide in patients with frailty and newly diagnosed multiple myeloma (IFM2017-03): a phase 3, open-label, multicentre, randomised, controlled trial.

The Lancet. Oncology·2025
Same journal

[Advances and perspectives in vascularized composite allotransplantation preservation].

Bulletin de l'Academie nationale de medecine·2025
Same journal

[COVID-19: Neurological manifestations and complications during the acute phase of the disease].

Bulletin de l'Academie nationale de medecine·2024
Same journal

[Role of psychological factors in post-COVID-19 condition].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[From the origin of Sars-CoV-2 to dangerous virology/biology].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Neurological forms of long COVID in adults: Critical approach].

Bulletin de l'Academie nationale de medecine·2023
Same journal

[Post-COVID-19 syndrome].

Bulletin de l'Academie nationale de medecine·2023
See all related articles

Iron deficiency affects 1.2 billion globally, with distinct stages from depleted stores to anemia. Management varies by risk group, often involving oral iron supplementation and endoscopic investigation for gastrointestinal bleeding.

Area of Science:

  • Nutritional Science
  • Hematology
  • Gastroenterology

Context:

  • Iron deficiency is the most prevalent nutritional disorder worldwide, impacting over 1.2 billion individuals.
  • It poses a significant public health challenge in both developing and industrialized nations.
  • Three distinct stages exist: iron store depletion, iron-deficient erythropoiesis, and iron-deficiency anemia.

Purpose:

  • To outline the diagnostic and management strategies for iron deficiency based on clinical context and patient risk factors.
  • To differentiate investigation pathways for at-risk populations versus those suspected of gastrointestinal bleeding.
  • To detail treatment protocols including oral iron supplementation and endoscopic evaluations.

Summary:

  • Investigations for iron deficiency must consider the clinical background.

Related Experiment Videos

  • Management strategies differ for at-risk groups (e.g., children, women of childbearing age, pregnant women) versus men and post-menopausal women.
  • Endoscopic procedures like upper/lower endoscopy and video-capsule endoscopy are crucial for diagnosing occult gastrointestinal bleeding, while oral ferrous salts are the standard treatment.

    • Impact:

    • Provides a clear framework for diagnosing and managing iron deficiency, a widespread health issue.
    • Highlights the importance of tailored approaches based on patient demographics and suspected etiology.
    • Emphasizes the role of gastrointestinal investigations in identifying underlying causes of iron deficiency in specific populations.